HSA
AMPH icon

Hussman Strategic Advisors’s Amphastar Pharmaceuticals AMPH Stock Holding History

Hussman Strategic Advisors’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.23M Buy
+63,000
New +$1.54M 0.27% 172
2025
Q2 		– Sell
-31,500
Closed -$913K – 216
2025
Q1 		$913K Buy
+31,500
New +$1.01M 0.22% 170
2024
Q3 		– Sell
-63,000
Closed -$2.52M – 225
2024
Q2 		$2.52M Hold
63,000
– – 0.69% 49
2024
Q1 		$2.77M Buy
+63,000
New +$3.25M 0.64% 62

Other funds holding AMPH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $12.2B AUM 12.45% 1-Year Est. Return

Hussman Strategic Advisors's AMPH Position: Q1 2026 in Review

Hussman Strategic Advisors opened a new position in Amphastar Pharmaceuticals (AMPH) in Q1 2026: 63,000 shares worth $1.23M. The stake represents 0.27% of the portfolio and ranks #172 among its holdings. This is a return to the name: Hussman Strategic Advisors previously reported a position in AMPH as recently as Q1 2025.

Hussman Strategic Advisors first reported a position in AMPH in Q1 2024 and has held it in 4 quarters since. The position peaked at $2.77M in Q1 2024. 215 funds tracked by Wall St. Rank hold AMPH as of Q1 2026.

  • Hussman Strategic Advisors held 63,000 shares of Amphastar Pharmaceuticals worth $1.23M as of Q1 2026.
  • Amphastar Pharmaceuticals was a new Hussman Strategic Advisors position in Q1 2026.
  • Amphastar Pharmaceuticals made up 0.27% of Hussman Strategic Advisors's portfolio in Q1 2026, its #172 holding.
  • Hussman Strategic Advisors first reported a position in Amphastar Pharmaceuticals in Q1 2024 and has held it in 4 quarters since.
  • Hussman Strategic Advisors's Amphastar Pharmaceuticals position peaked at $2.77M in Q1 2024.
  • 215 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q1 2026.

Based on Hussman Strategic Advisors's 13F filing for Q1 2026, filed 11 May 2026.